BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33380794)

  • 1. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine.
    Chen Y; Liu Y; Xie J; Zheng Q; Yue P; Chen L; Hu P; Yang M
    Int J Nanomedicine; 2020; 15():10435-10451. PubMed ID: 33380794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
    Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
    Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin.
    Fahmy UA; Ahmed OAA; Badr-Eldin SM; Aldawsari HM; Okbazghi SZ; Awan ZA; Bakhrebah MA; Alomary MN; Abdulaal WH; Medina C; Alhakamy NA
    Int J Nanomedicine; 2020; 15():5253-5264. PubMed ID: 32801690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery.
    Sun Y; Li L; Xie H; Wang Y; Gao S; Zhang L; Bo F; Yang S; Feng A
    Int J Nanomedicine; 2020; 15():3137-3160. PubMed ID: 32440115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization.
    Saindane NS; Pagar KP; Vavia PR
    AAPS PharmSciTech; 2013 Mar; 14(1):189-99. PubMed ID: 23255198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
    Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
    Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
    Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of huperzine A nasal in situ gel and evaluation of its brain targeting following intranasal administration].
    Tao T; Zhao Y; Yue P; Dong WX; Chen QH
    Yao Xue Xue Bao; 2006 Nov; 41(11):1104-10. PubMed ID: 17262956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nose-to-brain delivery of teriflunomide-loaded lipid-based carbopol-gellan gum nanogel for glioma: Pharmacological and in vitro cytotoxicity studies.
    Gadhave D; Rasal N; Sonawane R; Sekar M; Kokare C
    Int J Biol Macromol; 2021 Jan; 167():906-920. PubMed ID: 33186648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
    Galgatte UC; Kumbhar AB; Chaudhari PD
    Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin.
    Cai Z; Song X; Sun F; Yang Z; Hou S; Liu Z
    AAPS PharmSciTech; 2011 Dec; 12(4):1102-9. PubMed ID: 21879392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nose-to-brain delivery of drug nanocrystals by using Ca
    Huang G; Xie J; Shuai S; Wei S; Chen Y; Guan Z; Zheng Q; Yue P; Wang C
    Int J Pharm; 2021 Feb; 594():120182. PubMed ID: 33346126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder.
    Zhang T; Li X; Xu J; Shao J; Ding M; Shi S
    Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method.
    Yang G; Li Z; Wu F; Chen M; Wang R; Zhu H; Li Q; Yuan Y
    Int J Nanomedicine; 2020; 15():1661-1675. PubMed ID: 32210559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies.
    Elsenosy FM; Abdelbary GA; Elshafeey AH; Elsayed I; Fares AR
    Int J Nanomedicine; 2020; 15():9517-9537. PubMed ID: 33324051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
    Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
    Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
    [No Abstract]   [Full Text] [Related]  

  • 17. Mixed polyethylene glycol-modified breviscapine-loaded solid lipid nanoparticles for improved brain bioavailability: preparation, characterization, and in vivo cerebral microdialysis evaluation in adult Sprague Dawley rats.
    Liu Z; Okeke CI; Zhang L; Zhao H; Li J; Aggrey MO; Li N; Guo X; Pang X; Fan L; Guo L
    AAPS PharmSciTech; 2014 Apr; 15(2):483-96. PubMed ID: 24482026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
    Singh MK; Pooja D; Ravuri HG; Gunukula A; Kulhari H; Sistla R
    Phytomedicine; 2018 Feb; 40():48-54. PubMed ID: 29496174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel redispersible nanosuspensions stabilized by co-processed nanocrystalline cellulose-sodium carboxymethyl starch for enhancing dissolution and oral bioavailability of baicalin.
    Xie J; Luo Y; Liu Y; Ma Y; Yue P; Yang M
    Int J Nanomedicine; 2019; 14():353-369. PubMed ID: 30655668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing ophthalmic delivery of a poorly water soluble drug from an aqueous in situ gelling system.
    Senjoti FG; Timmins P; Conway BR; Smith AM
    Eur J Pharm Biopharm; 2020 Sep; 154():1-7. PubMed ID: 32599271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.